CPI Logo-Color.png
Constellation Pharmaceuticals Provides an Update from the Ongoing MANIFEST Study of Pelabresib
June 11, 2021 09:00 ET | Constellation Pharmaceuticals , Inc.
Translational data support the disease-modifying potential of pelabresibCentral pathology review confirmed bone marrow fibrosis improvements observed with pelabresib treatment Impact of pelabresib...
CPI Logo-Color.png
Constellation Pharmaceuticals Presents Phase 1 Data for CPI-0209 at ASCO Annual Meeting
June 04, 2021 09:00 ET | Constellation Pharmaceuticals , Inc.
Pharmacodynamic data show comprehensive target engagement after treatment with CPI-0209 monotherapyOral, once-daily 350mg dose selected for Phase 2Enrollment of tumor-specific expansion cohorts is...
CPI Logo-Color.png
Constellation Pharmaceuticals to Participate in Jefferies Virtual Healthcare Conference
May 31, 2021 09:00 ET | Constellation Pharmaceuticals , Inc.
CAMBRIDGE, Mass., May 31, 2021 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover...
CPI Logo-Color.png
Constellation Pharmaceuticals Announces First-Quarter 2021 Financial Results and Provides Business Update
May 10, 2021 07:00 ET | Constellation Pharmaceuticals , Inc.
Dosing underway in the Phase 3 MANIFEST-2 clinical trialRecommended Phase 2 dose determined for CPI-0209 and first patient dosed in the Phase 2 expansion cohortsUpcoming data presentation at ASCO...
CPI Logo-Color.png
Constellation Pharmaceuticals to Host Conference Call to Discuss First Quarter 2021 Results
April 27, 2021 11:30 ET | Constellation Pharmaceuticals , Inc.
CAMBRIDGE, Mass., April 27, 2021 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel...
CPI Logo-Color.png
Constellation Pharmaceuticals Announces Fourth-Quarter and Full-Year 2020 Financial Results
February 24, 2021 07:00 ET | Constellation Pharmaceuticals , Inc.
CAMBRIDGE, Mass., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop...
CPI Logo-Color.png
Constellation Pharmaceuticals to Participate in the 10th Annual SVB Leerink Global Healthcare Conference
February 19, 2021 16:00 ET | Constellation Pharmaceuticals , Inc.
CAMBRIDGE, Mass., Feb. 19, 2021 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover...
CPI Logo-Color.png
Constellation Pharmaceuticals to Host Conference Call to Discuss Fourth Quarter 2020 Results
February 18, 2021 10:00 ET | Constellation Pharmaceuticals , Inc.
CAMBRIDGE, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop...
CPI Logo-Color.png
Constellation Pharmaceuticals Appoints Brendan Delaney as Chief Commercial Officer
January 07, 2021 09:30 ET | Constellation Pharmaceuticals , Inc.
CAMBRIDGE, Mass., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc. (Nasdaq: CNST) today announced the appointment of Brendan Delaney to the newly created position of Chief...
CPI Logo-Color.png
Constellation Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
January 06, 2021 10:00 ET | Constellation Pharmaceuticals , Inc.
CAMBRIDGE, Mass., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc. (Nasdaq: CNST) today announced that Jigar Raythatha, CEO, will present a company overview at the J.P....